VINZENZ GRUPPE
     
 

Cardiac involvement in AL amyloidosis is a marker of cardiac and noncardiac death in patients undergoing treatment with intensive intravenous melphalan therapy (Abstract)

Reisinger, J., Mendes, L. A., Dubrey, S. W., Comenzo, R., Vosburgh, E., Sanchorawala, V., Skinner, M. and Falk, R. H. (1997) Cardiac involvement in AL amyloidosis is a marker of cardiac and noncardiac death in patients undergoing treatment with intensive intravenous melphalan therapy (Abstract). Circulation, 96. I-697.

Full text not available from this repository.
Item Type: Article
Divisions: Ordensklinikum Linz Barmherzige Schwestern > Interne II - Kardiologie
Depositing User: Dr. Christian Vogel
Date Deposited: 08 Jan 2013 14:41
Last Modified: 24 Apr 2013 13:46
URI: http://eprints.vinzenzgruppe.at/id/eprint/60

Actions (login required)

View Item
View Item